Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Is the PR new news?

Well, the PR states:

The TPL Group, and Alliacense announced today that during December 2010 and January 2011, MMP Patent Portfolio licenses were entered into with several companies in the telecommunications and industrial equipment industry segments.

The 10Q filing is for the period ending November 30 2011.

Share
New Message
Please login to post a reply